You are here: Home > For Researchers > Projects > UNMUTED - Understanding Music-Based Interventions to Encourage Social- Emotional Development in Groups of Adults with Autism Spectrum Disorder

UNMUTED - Understanding Music-Based Interventions to Encourage Social- Emotional Development in Groups of Adults with Autism Spectrum Disorder

From 01-01-2021 to 31-12-2024

Description

Approximately 10% of adult psychiatric inpatients in Europe are individuals with Autism Spectrum Disorders (ASD). Current therapies for these inpatients emphasize cognitive adjustment and do not account for specific qualities of autism. Recent research emphasizes the need to integrate modern therapies in a non-verbal, affectiveembodied oriented framework. One such framework, music-based intervention, has become a powerful tool for enhancing socialemotional competence in children with ASD, but little is known about the effects of this approach on adults with ASD. This proposal, therefore, aims to renew scientific knowledge about the ways in which music-based interventions foster social-emotional development in a population of adults with ASD. In contrast with current studies that focus on outcome measures or success rates of interventions, we will target a mechanistic and multimodal understanding of the key components of action, and their processes, in music-based interventions. We propose a four-step, multidisciplinary plan that expands on our ongoing work in which we will (1) collect audio recordings and other non-musical information from group-based music interventions, (2) extract relevant features from those data, (3) create models that describe developmental processes within single interventions and across interventions, and (4) use those models to inform and improve future music-based interventions, and arts-based interventions in general.

Team

Financing

Funding: FWO - Research Foundation - Flanders

Program/Grant Type: FWO Project - FWO Research Project

Events

2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery


3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery


12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers


More events

News

STADIUS Alumni Herman Verrelst – new CEO of Biocartis

08 June 2017

Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.


Supporting healthcare policymaking via machine learning – batteries included!

29 May 2017

STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.


Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"

10 February 2017

Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?


Joos Vandewalle is nieuwe voorzitter KVAB

09 October 2016

Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.


More news

Logo STADIUS